Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rubin

Showing results (91-100 of 1,970) with videos related to

Pageof 197
Sort By:
The New England Journal of Medicine|January 24, 2014
Troubles with tuberculosis preventionEric J Rubin
Life Sciences|August 14, 2012
Endothelin receptor antagonists for the treatment of pulmonary artery hypertensionLewis J Rubin
The New England Journal of Medicine|May 17, 2023
Making the Worm TurnEric J Rubin
The New England Journal of Medicine|June 30, 2026
Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609Eric J Rubin
Nephrology News & Issues|April 1, 1997
"Freedom of choice" argument may end shielding ESRD from managed careR J Rubin
The Yale Journal of Biology and Medicine|September 1, 1984
Diagnostic virology laboratory within a microbiology settingS J Rubin
Annals of the American Thoracic Society|February 21, 2018
Cor Pulmonale Revisited. From Ferrer and Harvey to the PresentLewis J Rubin
Nature Microbiology|February 22, 2018
TB diagnosis from the Dark Ages to fluorescenceEric J Rubin
Circulation|February 15, 2018
Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic MeasurementsLewis J Rubin
The Journal of Medical Practice Management : MPM|December 22, 2006
Meanwhile, healthcare issues worth watchingRobert J Rubin
Pageof 197

Showing results (91-100 of 1,970) with videos related to

Sort By:
Pageof 197
The New England Journal of Medicine|January 24, 2014
Troubles with tuberculosis preventionEric J Rubin
Life Sciences|August 14, 2012
Endothelin receptor antagonists for the treatment of pulmonary artery hypertensionLewis J Rubin
The New England Journal of Medicine|May 17, 2023
Making the Worm TurnEric J Rubin
The New England Journal of Medicine|June 30, 2026
Retraction: Jayne DRW et al. Avacopan for the Treatment of ANCA-Associated Vasculitis, N Engl J Med 2021;384:599-609Eric J Rubin
Nephrology News & Issues|April 1, 1997
"Freedom of choice" argument may end shielding ESRD from managed careR J Rubin
The Yale Journal of Biology and Medicine|September 1, 1984
Diagnostic virology laboratory within a microbiology settingS J Rubin
Annals of the American Thoracic Society|February 21, 2018
Cor Pulmonale Revisited. From Ferrer and Harvey to the PresentLewis J Rubin
Nature Microbiology|February 22, 2018
TB diagnosis from the Dark Ages to fluorescenceEric J Rubin
Circulation|February 15, 2018
Assessing Prognosis of Pulmonary Arterial Hypertension in the Therapeutic Era: Importance of Serial Hemodynamic MeasurementsLewis J Rubin
The Journal of Medical Practice Management : MPM|December 22, 2006
Meanwhile, healthcare issues worth watchingRobert J Rubin
Pageof 197